ER/PR+ and HER2+ Survival Rate:
HER2+ only Survival Rate:
ER/PR+ only Survival Rate:
TNBC Survival Rate:
Reference
Gong Y, Liu Y-R, Ji P, Hu X, Shao Z-M. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Scientific Reports. 2017;7:45411. doi:10.1038/srep45411.